Keywords
Tirotoxicosis
hipertiroidismo
hipertiroidismo
How to Cite
Fletcher, P. E., Isaacs, F., Lasso de la Vega, R., Sierra Zarak, A., & Trejos, J. (2018). Revisión de 644 casos de Tirotoxicosis. Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo, -10(1), 50–56. https://doi.org/10.53853/encr.-10.1.206
Abstract
Fragmento
INTRODUCCION
Actualmente se considera como hipertiroidismo el síndrome determinado por el aumento en los niveles sanguíneos de la tiroxima libre, cuyos valores normales oscilan cerca de los 3 ng + 0.5 por 100/ml. Este síndrome puede producirse por la administración de hormona tiroidea (T4 ó T3), hormona estimulante tiroidea (TSH) o de hormona liberadora tiroidea (TRH). Sabemos también que el hipertiroidismo se produce transitoriamente durante la tiroiditis sub-aguda o la radiación tiroidea o por tumores secretorios hipofisiarios de TSH.
References
1.-Fenberg W. D., D. L. Hoffman, and C. A. Owen: The effects of varying amounts of stable iodine on the function of the human thyroid, J. Clin. Endocrinol. Metab., 19: 567, 1959.
2-Werner, S. C. and M. Spooner: A new and simple test for hiperthyroidism employing L-tri odothyronine and the twenty-four I131 uptake methods, Bull. N. Y. Acad. Med., 31: 137, 1955.
3-Dobyns, B. M. A. Wright, and L. Wilson: Assay of the exophthalmos-producing substance in the serum of patients with progressive exophthalmos, J. Clin, Endocrinol. Metab., 21: 648, 1961.
4.--Adams, D., D.: The presence of an abnormal thyroid stimulating hormone in the serum of some thyrotoxic patients, J. Clin. Endocrinol. Metab., 18: 699, 1958.
5-McKenzie, J. M.: Further evidence for a thyroid activator in hyperthyroidism, J. Clin. Endocrinol, Metab., 20:380, 1960.
6.-McKenzie, J. M.: Studies on the thyroid activator of hyperthyroid sm, J. Clin, Endocrinol, Metab, 21: 635, 1961.
7.-Adams, D. D., H. D. Purves, N. E. Sirett, and D. W. Beaven: The presence of a short-acting thyroid stimulator in the blood of a thyrotoxic patient, J. Clin. Endocrinol. Metab., 22: 623, 1962.
8.-Werner S. C., The eye changes of Graves" disease: Overview. Second T. Raymond Keatyng, Jr., Memorial Symposium, 969, Mayo Clinic, Rochester, Minmesota, April, 1972.
9.-Volpé R. et. al. The pathogenesis of Graves' Disease a disorder of Delayed. Hypersensitivity? Second T. Raymond, Keating, Jr., Memorial Symposium, 824. Mayo Clin c, Rochester, Minnesota, April, 1972.
10.-Ingbard S. H. Autoregulations of the Thyroid: Response to iodide excess and depretion. Second T. Raymond Keating. Jr., Memorial Symposium, 814, Mayo Clinic, Rochester, Minnesota, April, 1972.
11-Wahner H. W., T. Hyperthyroidis. Second T. Raymond Keating, Jr., Memorial Symposium, 938, Mayo Clinic, Rochester, Minnesota, April, 1972.
12.-Hall, R. Doniach, D. Kirkham, H. and El Kabir, D. (1970): ophtalmic Graves' disease, Lancet, 1,375.
13.-Cavalieri, R. R. (1961) : Hyperthyroïdism and decreased Thyroxime binding by serum proteins. J. Clin Endocri, 21. 1455.
14. -Becker D. V. et, al. The impact of Technology on Clinical practice in Graves´´ Disease. Second T. Raymond Keating, Jr., Memorial Symposium, 835, Mayo Clinic, Rochester, Minnesota, April, 1972.
15.-Fletcher et al. Explosión de Hipertiroidismo en Panamá (1969-1973). Memorias del VIII Congreso Panamericano de Endocrinología. Buenos Aires, Argentina, 26 de oct. - 19 de now., 1974.
16.-Fletcher et al. Pruebas Funcionales hepáticas en el Hipertiroidismo. IV Congreso Bolvariano de Endocrinologia. Panamá, Panamá. 28 de nov. - 7 de dic., 1973.
17.-Fletcher et. al. Tirotoxicosis y Psicopatía, IV Congreso Bolivariano de Endocrinología. Panamá, Panamá. 28 de nov. 19 de dic., 1973.
2-Werner, S. C. and M. Spooner: A new and simple test for hiperthyroidism employing L-tri odothyronine and the twenty-four I131 uptake methods, Bull. N. Y. Acad. Med., 31: 137, 1955.
3-Dobyns, B. M. A. Wright, and L. Wilson: Assay of the exophthalmos-producing substance in the serum of patients with progressive exophthalmos, J. Clin, Endocrinol. Metab., 21: 648, 1961.
4.--Adams, D., D.: The presence of an abnormal thyroid stimulating hormone in the serum of some thyrotoxic patients, J. Clin. Endocrinol. Metab., 18: 699, 1958.
5-McKenzie, J. M.: Further evidence for a thyroid activator in hyperthyroidism, J. Clin. Endocrinol, Metab., 20:380, 1960.
6.-McKenzie, J. M.: Studies on the thyroid activator of hyperthyroid sm, J. Clin, Endocrinol, Metab, 21: 635, 1961.
7.-Adams, D. D., H. D. Purves, N. E. Sirett, and D. W. Beaven: The presence of a short-acting thyroid stimulator in the blood of a thyrotoxic patient, J. Clin. Endocrinol. Metab., 22: 623, 1962.
8.-Werner S. C., The eye changes of Graves" disease: Overview. Second T. Raymond Keatyng, Jr., Memorial Symposium, 969, Mayo Clinic, Rochester, Minmesota, April, 1972.
9.-Volpé R. et. al. The pathogenesis of Graves' Disease a disorder of Delayed. Hypersensitivity? Second T. Raymond, Keating, Jr., Memorial Symposium, 824. Mayo Clin c, Rochester, Minnesota, April, 1972.
10.-Ingbard S. H. Autoregulations of the Thyroid: Response to iodide excess and depretion. Second T. Raymond Keating. Jr., Memorial Symposium, 814, Mayo Clinic, Rochester, Minnesota, April, 1972.
11-Wahner H. W., T. Hyperthyroidis. Second T. Raymond Keating, Jr., Memorial Symposium, 938, Mayo Clinic, Rochester, Minnesota, April, 1972.
12.-Hall, R. Doniach, D. Kirkham, H. and El Kabir, D. (1970): ophtalmic Graves' disease, Lancet, 1,375.
13.-Cavalieri, R. R. (1961) : Hyperthyroïdism and decreased Thyroxime binding by serum proteins. J. Clin Endocri, 21. 1455.
14. -Becker D. V. et, al. The impact of Technology on Clinical practice in Graves´´ Disease. Second T. Raymond Keating, Jr., Memorial Symposium, 835, Mayo Clinic, Rochester, Minnesota, April, 1972.
15.-Fletcher et al. Explosión de Hipertiroidismo en Panamá (1969-1973). Memorias del VIII Congreso Panamericano de Endocrinología. Buenos Aires, Argentina, 26 de oct. - 19 de now., 1974.
16.-Fletcher et al. Pruebas Funcionales hepáticas en el Hipertiroidismo. IV Congreso Bolvariano de Endocrinologia. Panamá, Panamá. 28 de nov. - 7 de dic., 1973.
17.-Fletcher et. al. Tirotoxicosis y Psicopatía, IV Congreso Bolivariano de Endocrinología. Panamá, Panamá. 28 de nov. 19 de dic., 1973.
Authors must state that they reviewed, validated and approved the manuscript's publication. Moreover, they must sign a model release that should be sent. A copy may be reviewed here